In parallel, healthcare providers are increasingly integrating remote monitoring and teleconsultation services to support long-term GLP-1 therapy management in home settings
Rebound or retention: A meta-analysis of weight regain after the discontinuation of glucagon-like peptide-1 (GLP-1) receptor agonists and other anti-obesity drugs
From Weight Loss to Lasting Value: Structured Exercise and the Economics of GLP-1 Therapy This white paper is complimentary
Flow cytometry and sorting For surface staining cells were incubated at 48 C, in the dark with fluorochrome-conjugated CD19, CD23, CD21-CD35 or CD35, IgD, IgM, CD1d, CD24, CD93, CD95, and GL-7 diluted 1:200 (refer to Supplementary Data 4 for details)
If you can maintain a healthy weight based on your lifestyle changes, your doctor may recommend that you discontinue the treatment